◢ TECHNICA.BIOBIOTECH ECOSYSTEM INTELLIGENCE
Polish Biotech Scene

Saventic Health

AI diagnostics · Rare-disease detection

MarketVC-backed (private)ToruńAI-Driven Drug Discovery
Focus / modality
AI diagnostics
Lead asset
AI rare-disease dx
Type
Diagnostics / AI
Indication
Rare-disease detection
Stage
Market
HQ
Toruń
Capital tier
VC-backed (private)
Backing
VC

Overview

AI decision support that flags rare diseases from routine clinical data to cut the diagnostic odyssey.

What they do

Saventic Health is a Polish health-AI company founded in 2019 and based in Warsaw. It builds AI decision-support algorithms that analyze routine electronic medical records and clinical data to flag patients at high risk of rare diseases, helping clinicians shorten the often years-long "diagnostic odyssey." The platform (marketed as Saventic Med/Saventic Care) is typically installed on a local server at a hospital, scans anonymized patient data, and generates risk reports for medical teams.

Lead program & status

Saventic is a commercial-stage software company rather than a drug developer. Its algorithms reportedly cover around 50 rare diseases for which treatments exist. As of 2024-2025 it works with 30+ clinics and hospitals across Poland, Germany, France, Brazil and Canada, and reports having referred over 300 individuals for further rare-disease diagnosis within a year. It raised roughly EUR 2.1 million in 2022 and reportedly a further bridge round (around EUR 1.9 million) led by 4growth VC with NCBR and US-based TNI to expand into new markets including Austria, Sweden, Spain and Italy.

Why it matters

By surfacing rare diseases hidden in existing data, Saventic addresses one of medicine's hardest problems: diagnostic delay for patients with treatable but under-recognized conditions.

FAQ

How does Saventic Health work?
Its AI scans routine, anonymized clinical and EMR data on a local hospital server to flag patients at high risk of rare diseases and generate reports that help clinicians act faster.
How many rare diseases does it cover?
The company reports algorithms for roughly 50 rare diseases, focusing on conditions for which treatments are available.
Where does Saventic operate?
As of 2024-2025 it works with 30+ clinics and hospitals across countries including Poland, Germany, France, Brazil and Canada, with expansion plans into further European and South American markets.

Technology

Saventic Health works in AI-Driven Drug Discovery — Compressing years of trial-and-error chemistry into months of computation.

Read the AI-Driven Drug Discovery brief →

Related companies

Company website / source ↗ Open the interactive map →

◢ Boom-cycle briefing

Get ahead of the next biotech boom.

New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.

No spam · ~1–2 emails/month · unsubscribe anytime.
Curated biotech intelligence, compiled for orientation — not investment advice. Company stages, deals and figures move fast; verify against ClinicalTrials.gov, company filings and primary sources before acting.